Literature DB >> 11498752

Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.

J C Voltarelli1, H Ahmed, E J Paton, A B Stracieri, P Holman, A Bashey, M Coutinho, B P Simoes, E D Ball, E Carrier.   

Abstract

We report two cases of refractory chronic graft-versus-host disease after donor lymphocyte infusions in which the skin lesions improved dramatically with the use of intravenous pulses of lidocaine. This form of therapy has been used successfully for the cutaneous involvement of scleroderma and may have vasodilator and anti-inflammatory effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498752     DOI: 10.1038/sj.bmt.1703080

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  1 in total

1.  Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions.

Authors:  C Phipps; M T Lupo-Stanghellini; M E D Flowers
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.